Find similar content

Source channel @githubtrending · Post #14919 · Jul 6

#cplusplus#aes#avx#avx_instructions#chrome#chrome_devtools#chromedriver#chromium#chromium_browser#content_shell#jpeg_xl#jpegxl#jxl#libjxl#linux#thorium#thorium_browser#thoriumos#web_browser#web_platform#webbrowser Thorium is a fast, optimized web browser based on Chromium, designed to work well on modern CPUs with advanced instruction sets like AVX and SSE4. It offers better performance than standard Chromium and Chrome, opening tabs and rendering pages quickly. Thorium includes enhanced privacy features such as DNS over HTTPS and Do Not Track enabled by default, plus support for modern media formats like HEVC and JPEG XL. It keeps the familiar Chrome interface and supports all Chrome extensions, making it easy to switch. Available on Windows, Linux, macOS, Android, and Raspberry Pi, it suits users wanting speed, privacy, and compatibility across devices[3][5][1]. https://github.com/Alex313031/thorium

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment